Zinger Key Points
- Shares of Genius Sports dropped 12.1% on Tuesday.
- The company reported Q1 financial results.
- Get access to the leaderboards pointing to tomorrow’s biggest stock movers.
Shares of Genius Sports Ltd GENI dropped 13.4% to $9.54 on Tuesday after the company reported a slight first-quarter revenue miss, posting $143.99 million against analysts' estimates of $144.06 million.
Despite the revenue miss, the company beat EPS expectations, reporting a loss of 3 cents per share, narrower than the 4 cents projected and an improvement from last year’s 11 cent loss.
What To Know: Revenue rose 20% year-over-year, driven by a 44% jump in its core betting technology segment, though media-related revenue declined 27%. Adjusted EBITDA soared 188% to $19.8 million, with margins expanding to 13.7%.
Genius reaffirmed its 2025 revenue guidance of $620 million, signaling confidence in sustained growth, profitability, and cash flow. CEO Mark Locke emphasized continued momentum in technology and product innovation.
The company also announced a $100 million share repurchase program. Recent initiatives include expanding fan engagement tools and securing exclusive NCAA data rights through 2032.
Read Also: US Trade Deficit Soars To Record $140B As Imports Rocket Ahead Of Trump’s Tariffs
How To Buy GENI Stock
Besides going to a brokerage platform to purchase a share – or fractional share – of stock, you can also gain access to shares either by buying an exchange traded fund (ETF) that holds the stock itself, or by allocating yourself to a strategy in your 401(k) that would seek to acquire shares in a mutual fund or other instrument.
For example, in Genius Sports’ case, it is in the Consumer Discretionary sector. An ETF will likely hold shares in many liquid and large companies that help track that sector, allowing an investor to gain exposure to the trends within that segment.
According to data from Benzinga Pro, GENI has a 52-week high of $11.40 and a 52-week low of $5.03.
Edge Rankings
Price Trend
© 2025 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.